Evaluation of wearable devices by comparing with PSG

Evaluation of wearable devices by comparing with PSG - Evaluation of wearable devices

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043119

Enrollment

Registered

2021-01-28

Start date

2021-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep apnea syndrome

Interventions

Wear wearable devices during the PSG test, up to 10 hours.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with PSG test. Patietns who can agree with informed consent forms.

Exclusion criteria

Exclusion criteria: Patients who cannot wear wearable devices. Patietns who cannot agree with informed consent forms.

Design outcomes

Primary

Measure	Time frame
SpO2	—

Secondary

Measure	Time frame
Heart late, Sleep depth	—

Countries

Japan

Contacts

Public ContactKammei Rai

Okayama University Hospital Allergy and Respiratory medicine (Hospital-based cancer registry division)

rai@okayama-u.ac.jp086-235-7227

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026